Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	Mirabegron 25 mg (Never Up-titrated)	0	44
Total, all-cause mortality	Mirabegron 25 mg (Later Up-titrated to 50 mg)	0	39
Total, all-cause mortality	Mirabegron 50 mg (Up-titrated From 25 mg)	0	39
Total, all-cause mortality	Mirabegron 50 mg	0	165
Total, other adverse events	Mirabegron 25 mg (Never Up-titrated)	1	44
Total, other adverse events	Mirabegron 25 mg (Later Up-titrated to 50 mg)	0	39
Total, other adverse events	Mirabegron 50 mg (Up-titrated From 25 mg)	3	39
Total, other adverse events	Mirabegron 50 mg	6	165
Total, serious adverse events	Mirabegron 25 mg (Never Up-titrated)	3	44
Total, serious adverse events	Mirabegron 25 mg (Later Up-titrated to 50 mg)	1	39
Total, serious adverse events	Mirabegron 50 mg (Up-titrated From 25 mg)	2	39
Total, serious adverse events	Mirabegron 50 mg	8	165

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04562090/event-totals